Arca Biopharma | ABIO - Ebitda





Ebitda Alterar Data
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
Arca Biopharma USD -25.07M 5.23M 2025-03
Biogen USD 649.7M 76.5M 2026-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cipla INR 9.55B 3B 2026-03
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -169.32M 19.48M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Grifols EUR 482.04M 7.04M 2025-09
Laboratory Of America USD 605.6M 17.5M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Otsuka Holdings JPY 156.66B 56.89B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
United Therapeutics USD 379.5M 83.4M 2025-12